Form S-1/A Estrella Immunopharma,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260116/AV22J22CL222N25L222M2MY2N35TW222Z282
Filed on: January 16, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Estrella Immunopharma adds fourth site to lymphoma trial
- Game Your Game receives order for 500 AI golf units from GolfSuites
- Silexion Therapeutics prices $2.5M public offering at $0.65 per share
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
